Physician
Malik, Faisal
Malik, Faisal was paid $75K by Medicaid between Nov 2021 and Feb 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.
33Billing provider infoMALIK, FAISAL
NORTH ANDOVER, MA 01845
NORTH ANDOVER, MA 01845
33aNPI1912106691assigned 07/13/2007
33bProvider typeInternal Medicine Physician
28Total paid$75K
24GClaims1,057
24DCodes billed7
24AFirst – last monthNov 2021 – Feb 2024
Compared with peers
Next to other Internal Medicine Physician providers in Massachusetts
Rank by total paid#255 of 1,270
Median peer was paid$8K
This provider vs. median8.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 200 | $14K | |
| 2022 | 552 | $40K | |
| 2023 | 278 | $19K | |
| 2024incomplete | 27 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 53% | 368 | 339 | $40K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27% | 237 | 237 | $20K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 11% | 260 | 250 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.9% | 49 | 49 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.6% | 49 | 49 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 82 | 82 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12 | 12 | $350.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.